Joan-En Chang-Lin

This inventor holds 29 USPTO granted patents and 13 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Ophthalmic Compositions. Top assignee: Allergan, Inc.. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joan-En Chang-Lin. Retrieved from https://idiyas.com/inventor/joan-en-chang-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 13)

% Patents Active = 69.0

CIPO Patents = 4

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 4.5

ph-index = 11

Forward Citations = 378(Granted Patents)

Company Filing History:

29 out of 2,287

Allergan, Inc.

patents

Years Active: 2010-2021

Loading Chart...

Areas of Expertise:

Biodegradable Implants

Tyrosine Kinase

Ophthalmic Solutions

Intraocular Transport

Bimatoprost

Drug Delivery

Therapeutic Agents

Sustained Release

Ocular Therapy

Alpha-2 Adrenergic Receptor

Enhanced Anterior Clearance

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10881608 - Biodegradable intravitreal tyrosine kinase implants (2021-01-05),

2. 10213405 - Ophthalmic compositions and methods for treating eyes (2019-02-26),

3. 10076492 - Biodegradable intravitreal tyrosine kinase implants (2018-09-18),

4. 9668997 - Ophthalmic compositions and methods for treating eyes (2017-06-06),

5. 9254324 - Ophthalmic compositions and methods for treating eyes (2016-02-09),

6. 9241918 - Enhanced bimatoprost ophthalmic solution (2016-01-26),

7. 9233070 - Biodegradable intravitreal tyrosine kinase implants (2016-01-12),

8. 9155716 - Enhanced bimatoprost ophthalmic solution (2015-10-13),

9. 8933127 - Enhanced bimatoprost ophthalmic solution (2015-01-13),

10. 8933120 - Enhanced bimatoprost ophthalmic solution (2015-01-13),

11. 8772338 - Enhanced bimatoprost ophthalmic solution (2014-07-08),

12. 8729125 - Ophthalmic compositions and methods for treating eyes (2014-05-20),

13. 8637571 - Compositions and methods for the intraocular transport of therapeutic agents (2014-01-28),

14. 8586630 - Enhanced bimatoprost ophthalmic solution (2013-11-19),

15. 8571802 - Method for determining optimum intraocular locations for drug delivery systems (2013-10-29),

Title: Inventor Joan-En Chang-Lin

Introduction: Joan-En Chang-Lin is a pioneering inventor based in Tustin, California. She is known for her groundbreaking work in the field of pharmaceuticals and biotechnology.

Latest Patents: Joan-En Chang-Lin holds several patents related to innovative drug delivery systems and novel pharmaceutical formulations that have revolutionized the industry.

Career Highlights: With a career spanning over two decades, Joan-En Chang-Lin has worked with leading research institutions and pharmaceutical companies to develop cutting-edge solutions for complex medical challenges. Her contributions have significantly impacted the healthcare landscape.

Collaborations: Throughout her career, Joan-En Chang-Lin has collaborated with top scientists, researchers, and medical professionals to bring her inventions to life. Her collaborative spirit has been instrumental in the success of many projects.

Conclusion: Joan-En Chang-Lin's dedication to innovation and her passion for improving healthcare have established her as a respected figure in the field of pharmaceutical inventions. Her work continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.